The highly variable amount of EpCAM+ cells found in patient blood was expected, since even in metastatic patients circulating tumor cells can be quite rare and heterogeneous in terms of EpCAM expression (which can be gained and lost, especially during HCC cancer progression) [28]. Here, EPCAM is linked to neoplasm.